- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04253600
Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder
Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder Original Public Title (French) : Projet ELENA, Etude Sur le développement du Langage Chez l'ENfAnt. Public Title (English) : Study on Infants' Language Development
For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental Language Disorder (DLD). Although the existence of a multi-factorial etiology has seemed to reach an agreement, presumably combining genetic and environmental factors to some kind of neural disruption, the underlying mechanisms leading to DLD are, to date, poorly understood.
Many studies have attempted to identify risk factors and early predictors associated with the future development of a language impairment. However, despite the constant efforts to identify early markers able to differentiate between transient and persistent language difficulties, early detection of children who will be developing a DLD remains highly difficult, partially due to the lack of direct and ecological measures of early language and communication development. In addition research on the causal neural correlates of DLD is in its infancy, and often compromised by small sample sizes or analyses methods that lack anatomical specificity to determine the neural correlates of language impairment.
Hence, In order to improve early detection and, therefore, language intervention, this longitudinal research project aims at investigating the early predictive factors as well as the neurocognitive basis of DLD by means of an integrative, multi-dimensional, and multi-methodological approach. To substantially gain insight, this research ideally integrates risk factors at multiple different levels, including the cognitive, neurobiological, parental and environmental level. From a methodological perspective, we will combine direct and indirect behavioral methods with neuroimaging methods in order to propose an early predictive model of language development.
Study Overview
Status
Intervention / Treatment
- Behavioral: Risk profile screening questionnaire
- Procedure: Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI)
- Behavioral: Online investigation of predictive factors associated with DLD and LANCOM app development
- Behavioral: Individual behavioral and cognitive assessment
- Behavioral: Automated analysis of language development and environment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jolijn Vanderauwera, Prof.
- Phone Number: +32470503454
- Email: jolijn.vanderauwera@uclouvain.be
Study Contact Backup
- Name: Camille Bonnet
- Phone Number: +32494172731
- Email: camille.bonnet@uclouvain.be
Study Locations
-
-
-
Louvain-la-Neuve, Belgium, 1348
- Institut de recherche en sciences psychologiques (IPSY, UCLouvain)
-
Contact:
- Jolijn Vanderauwera, Prof.
- Phone Number: +32470503454
- Email: jolijn.vanderauwera@uclouvain.be
-
Contact:
- Camille Bonnet
- Phone Number: +32494172731
- Email: camille.bonnet@uclouvain.be
-
Sub-Investigator:
- Marie Van Reybroeck, Prof.
-
Woluwe-Saint-Lambert, Belgium, 1200
- Institute of NeuroScience (IoNS, UCLouvain)
-
Contact:
- Jolijn Vanderauwera, Prof.
- Phone Number: +32470503454
- Email: jolijn.vanderauwera@uclouvain.be
-
Contact:
- Camille Bonnet
- Phone Number: +32494172731
- Email: camille.bonnet@uclouvain.be
-
Sub-Investigator:
- Laurence Dricot, Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having a child, preferably aged from 0 to 12 months, and a maximum of 18 months at the time of recruitment
- Having French as (one of) mother tongue(s)
Exclusion Criteria:
- Severe sensory deprivation resulting in hearing and/or visual impairment (i.e., deafness, blindness) detected at birth
- Chromosomal abnormalities (e.g., Down syndrome, Turner syndrome, Williams syndrome)
- Phenylketonuria
- Cleft lips or palates
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: MRI Acquisition
This does not refer to any group intervention.
At-risk and control children will take part in a natural-sleep MRI protocol.
|
Families will be asked to complete a LimeSurvey questionnaire that aims at evaluating general risk profiles associated with DLD (e.g., no elevated risk, behavioral risk, environmental risk, familial risk), as well as our exclusion criteria (e.g., hearing deficit).
MRI data acquisition will take place during natural sleep in infants aged from 6 to 12 months.
First, families will have to complete a security questionnaire to make sure that neither the children nor the accompanying parent have any known contraindication preventing the MRI session and that none of them is wearing any ferro-magnetic elements.
Then, families will be welcomed in a calm and child-friendly environment where we will propose them some preparatory games known to facilitate sleep in children.
MRI protocol will comprise structural and functional images and won't exceed 30 minutes.
Parents will be asked to complete a series of online questionnaires every six months.
Questionnaires will be created on LimeSurvey and will include different questionnaires, scales, and observations that aim at evaluating children's development, and especially language development, as well as parental and environmental characteristics.
Individual cognitive and behavioral assessment will be scheduled once a year, around the child's birth date, and will comprise an extensive battery of standardized evaluation appropriate for the child's age.
This individual evaluation will focus on several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning, depending on the age of the children.
Evaluations will be adapted to each child's specific profile, while respecting the following administration rules: (1) we will prioritize language development testing, (2) testing sessions will be adapted to each child's pace and possibilities, (3) if a child does not want to take part in the assessment, feels tired, or does not seem to be comfortable with the investigator, tests won't be administered.
Following the individual assessment, families will be asked to record their child's language environment over a 2-days' timeframe using the LENA® device, a "small wearable device allowing for large-scale all-day audio recording and automated vocal analyses of speech segments".
An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language.
Data acquisition will take place once a year following our sample selection, with a required recording time per day ranging from 12 to 16 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Environmental characteristics
Time Frame: From 6 months to 48 months of age
|
Online questionnaires to be completed by parents and evaluating environmental characteristics of the child.
|
From 6 months to 48 months of age
|
|
Parental characteristics
Time Frame: From 6 months to 48 months of age
|
Online questionnaires to be completed by parents and evaluating parental characteristics of the child.
|
From 6 months to 48 months of age
|
|
Children's behavioral characteristics (indirect measure)
Time Frame: From 6 months to 48 months of age
|
Online questionnaires to be completed by parents, which aims at evaluating children's development, and in particular, their language development.
|
From 6 months to 48 months of age
|
|
Cognitive and behavioral characteristics (direct measure) as assessed by standardized batteries of tests
Time Frame: From 1 year to 4 years of age
|
Individual cognitive and behavioral assessment evaluating several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning (e.g., EVALObb, EVALO2-6, WPPSI-IV).
We will use batteries of neuropsychological standardized evaluation appropriate for the child's age.
|
From 1 year to 4 years of age
|
|
Evaluation of children's language development and environment using the Language ENvironment Analysis digital language processor recording device (LENA)
Time Frame: From 1 year to 4 years of age
|
Automated analysis of language development and environment using the LENA device.
An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language.
|
From 1 year to 4 years of age
|
|
Magnetic Resonance Imagery analyses
Time Frame: 6-12 months old
|
Evaluation of neural correlates of DLD using structural (and functional) images.
Children aged from 6 months to 12(-18) months will be scanned only once.
|
6-12 months old
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk profiles analysis based on risk screening online questionnaire
Time Frame: 0-18 months old (at screening)
|
Evaluation of different risk profiles associated with the development of DLD (e.g., family risk, environmental risk) based on a risk screening online questionnaire to be completed by the parents.
|
0-18 months old (at screening)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ELENA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Language Development
-
IDeA States Pediatric Clinical Trials NetworkNational Institutes of Health (NIH); University of KansasRecruitingInfant Behavior | Infant Development | Language Development | Language | Language, Child | SpeechUnited States
-
Temple UniversityWilliam Penn FoundationRecruitingLanguage Development | Early Intervention | Language, ChildUnited States
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of MelbourneActive, not recruiting
-
Assiut UniversityCompleted
-
University of SheffieldCompleted
-
University of SheffieldUniversity of LeedsCompleted
-
Assiut UniversityNot yet recruiting
-
William Marsh Rice UniversityAlief Independent School DistrictRecruitingLanguage DevelopmentUnited States
-
Universidad de Costa RicaCaja Costarricense de Seguro SocialCompletedLanguage DevelopmentCosta Rica
Clinical Trials on Risk profile screening questionnaire
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; The New School for Social Research and other collaboratorsActive, not recruitingAdvanced CancerUnited States
-
Lena BornhoftRegion Västra Götaland, Sweden; Region Värmland, SwedenCompletedLifestyle Risk ReductionSweden
-
University Hospital, AntwerpKarolinska University Hospital; Karolinska Institutet; Rigshospitalet, Denmark; Heinrich-Heine University, Duesseldorf and other collaboratorsNot yet recruitingBarrett Esophagus | Gastroenterology | Barrett Esophagus Adenocarcinoma | Adenocarcinoma - GEJ | Gastroenterological CancerDenmark, Belgium, Sweden, Ireland, Italy, France, Germany
-
McGill UniversityPfizerCompletedHypertension | Obesity | Diabetes | Sedentary Lifestyle | Dyslipidemia | Cigarette SmokingCanada
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Karolinska InstitutetNot yet recruitingBreast Cancer
-
Institut de Recerca Biomèdica de LleidaInstitut Català de la Salut; Catalan Health ServiceCompleted
-
University Hospital, ToulouseCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingColorectal Cancer | Colorectal CarcinomaUnited States
-
Association pour le Développement et l'Organisation...RecruitingPulmonary Disease | DyspneaFrance